Meditor Group Ltd 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-03 11:02 am Sale | 2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 3,791,300 3.300% | -677,535 (-15.16%) | Filing |
| 2023-01-04 2:30 pm Unchanged | 2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 4,468,835 6.100% | 0 (Unchanged) | Filing |
| 2022-01-12 2:15 pm Purchase | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 4,468,835 7.100% | 1,789,000 (+66.76%) | Filing |
| 2021-01-06 2:37 pm Unchanged | 2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | Meditor Group Ltd | 2,679,835 9.600% | 0 (Unchanged) | Filing |